Callan JMB Corp (CJMB) - Multiplikator forward rega marang pendapatan

Callan JMB Inc. (CJMB) - logo korporat

Callan JMB Inc (CJMB) is optimizing logistics and implementing sustainable ESG standards into instrument production. This chart of the company's future P/S reflects the impact of Central Bank policy on revenue expectations, where 0.40 serves as the base parameter value. The brand is strengthening its authority among surgeons through device ergonomics, while management develops partnership networks with clinics to commercialize niche products.

CJMB Callan JMB: Multiplikator forward rega marang pendapatan ing interval 06.02.2025 - 13.11.2026

callanjmb.com - rincian analitis lan metrik utama (CJMB)

- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
Analisis umum perusahaan:CJMB (Callan JMB Corp)
Produk asli Callan JMB Inc.

This indicator is calculated as the ratio of current market capitalization to expected sales volume, allowing for an assessment of the business's market value through the lens of future cash flows. The trend of the forward price-to-sales ratio reflects the discounting of prospects for Callan JMB Inc. (CJMB), where the modernization of CNC workshops and stable capacity utilization of tool assembly lines should ensure sustainable growth in fundamental value.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Merit Medical Corp - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (icumed.com)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Vascular Inc LMAT|ATRC: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan STAAR Surgical Co|NAGE (ChromaDex Corporation) - Multiplikator Forward P/S|Multiplikator Forward P/S zimvie.com|Rasio rega marang prakiraan pendapatan AngioDynamics (ANGO)|Rasio rega marang prakiraan pendapatan CERS (Cerus Corp.)|Rasio rega marang prakiraan pendapatan Alpha Teknova Inc TKNO|Monogram Orthopedics Inc. - Rasio rega marang prakiraan pendapatan|Sharps Tech - Multiplikator Forward P/S|INFU - Multiplikator Forward P/S|Utah Medical Products, Inc. (UTMD) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan KRMD|Multiplikator forward rega marang pendapatan NYXH|MBOT: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Pro-Dex, Inc. (PDEX)|Rasio rega marang pendapatan sing dikarepake ZTEK|Rasio rega marang prakiraan pendapatan Elutia ELUT|MLSS - Multiplikator forward rega marang pendapatan|NEXGEL, Inc - Multiplikator Forward P/S|RVP: Rasio rega marang prakiraan pendapatan|HBIO (Harvard Bioscience, Inc.) - Multiplikator forward rega marang pendapatan|femasys.com - Rega forward marang dodolan|MHUA (Meihua Medical Technologies) - Multiplikator Forward P/S|Predictive Oncology Corp (POAI) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Atrion Corp (ATRI)|NeuroMetrix Corporation - Kapitalisasi marang prakiraan pendapatan